COPD non-acute phenotype with emphysema
DOI:
https://doi.org/10.32818/reccmi.a2n3a15Keywords:
non-exacerbator emphysema, treatment optimization, bullectomyAbstract
A 48-year-old male smoker with no other history of interest, who is referred for dyspnea. Following complementary tests, the diagnosis of COPD grade D GOLD, non-aggravating emphysema GesEPOC, was made, he has dyspnea grade 2-3 of MRCm with BODE score of 7 and presence of bullas of predominance in the right lung. After optimization medical treatment, removing inhaled corticosteroids, the clinical situation of the patient improves, but after 3 months there is a sudden worsening with the appearance of pneumothorax requiring drainage tube and bullectomy with posterior clinical and functional improvement.
Downloads
Metrics
References
Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol. 2012; 48: 247-257.
Nadeem NJ, Taylor SJ, Eldridge SM. Withdrawal of in-haled corticosteroids in individuals with COPD − a systematic review and comment on trial methodology. Respir Res. 2011; 12: 107.
Yawn BP, Suissa S, Rossi A. Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal. NPJ Prim Care Respir Med. 2016; 26: 16068.
Farne HA, Cates CJ. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015 Oct 22; 10: CD008989.
Van Bael K, La Meir M, Vanoverbeke H. Video-assisted Thoracoscopic Resection of a Giant Bulla in Vanishing Lung Syndrome: case report and a short literature review. J Cardiothorac Surg. 2014; 9: 4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Isabel Martín-Garrido, María Teresa Martínez-Rísquez, María Luz Calero-Bernal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
